Follow The Filings

BIO position history

The shares of Bio Rad Labs (BIO) that First Eagle Investment Management, LLC reported in each quarter’s 13F.

Equity, CL A

Shares held by quarter

New Add Reduce Exit

  1. 2023 Q2: 191 shares, $72K, <0.01% of portfolio, New
  2. 2023 Q3: 458 shares, $164K, <0.01% of portfolio, Add +139.8%
  3. 2023 Q4: 479 shares, $155K, <0.01% of portfolio, Add +4.6%
  4. 2024 Q1: 1,964 shares, $679K, <0.01% of portfolio, Add +310.0%
  5. 2024 Q2: 636,275 shares, $174M, 0.39% of portfolio, Add +32296.9%
  6. 2024 Q3: 713,000 shares, $239M, 0.49% of portfolio, Add +12.1%
  7. 2024 Q4: 713,505 shares, $234M, 0.52% of portfolio, Add +0.1%
  8. 2025 Q1: 1,566,190 shares, $381M, 0.80% of portfolio, Add +119.5%
  9. 2025 Q2: 2,517,313 shares, $607M, 1.2% of portfolio, Add +60.7%
  10. 2025 Q3: 2,520,319 shares, $707M, 1.3% of portfolio, Add +0.1%
  11. 2025 Q4: 2,570,473 shares, $779M, 1.4% of portfolio, Add +2.0%
  12. 2026 Q1: 5,205,544 shares, $1.5B, 2.2% of portfolio, Add +102.5%
  13. 2026 Q2: 2,606,219 shares, $765M, 1.3% of portfolio, Reduce −49.9%
Holdings date Value % of holdings Shares Filing date All 13F holders